{
  "schemaVersion" : 2,
  "registerId" : "F2012L02084",
  "instrumentNumber" : "73/2012",
  "citation" : "Statement of Principles concerning solar keratosis No. 73 of 2012",
  "conditionName" : "solar keratosis",
  "effectiveFrom" : "2012-10-31",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "L57.0"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "being a prisoner of war of Japan before the clinical onset of solar\r\nkeratosis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "having sunlight exposure to unprotected skin at the affected site for at\r\nleast 2250 hours while in a tropical area, or having equivalent sunlight\r\nexposure in other latitude zones, before the clinical onset of solar\r\nkeratosis",
    "definedTerms" : [ {
      "term" : "unprotected skin",
      "definition" : "means skin that is directly exposed to the sun and is not\nprotected by sunscreen, clothing or any other physical barrier"
    }, {
      "term" : "a tropical area",
      "definition" : "means any area between the Tropic of Capricorn (23ยบ 27'\nSouth) and the Tropic of Cancer (23ยบ 27' North)"
    } ]
  }, {
    "paragraph" : "6(c)",
    "text" : "being treated with an immunosuppressive drug for a continuous period\r\nof 12 weeks before the clinical onset of solar keratosis",
    "definedTerms" : [ {
      "term" : "an immunosuppressive drug",
      "definition" : "means a drug or an agent administered orally,\nintravenously or intramuscularly for the purpose of suppressing the immune\nresponses, but does not include an inhaled or topical steroid"
    } ]
  }, {
    "paragraph" : "6(d)",
    "text" : "undergoing PUVA therapy involving the affected site where:\r\n(i) the first PUVA treatment commenced at least five years before;\r\nand\r\n(ii) at least 25 PUVA treatments were administered;\r\nbefore the clinical onset of solar keratosis",
    "definedTerms" : [ {
      "term" : "PUVA",
      "definition" : "means photochemotherapy with oral methoxsalen (psoralen) and\nultraviolet A radiation"
    } ]
  }, {
    "paragraph" : "6(e)",
    "text" : "having cutaneous contact of the affected site with bipyridyl compounds\r\nassociated with paraquat manufacture, on more days than not for a\r\ncumulative period of at least five years, before the clinical onset of\r\nsolar keratosis",
    "definedTerms" : [ ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(f)",
    "text" : "inability to obtain appropriate clinical management for solar keratosis",
    "definedTerms" : [ ]
  } ]
}